Wang et al. describe a mouse model expressing ATDC (TRIM29) that, in the presence of oncogenic KRAS, accelerates PanIN formation and the development of invasive and metastatic pancreatic cancers. This evidence concerns the gene KRAS and familial pancreatic carcinoma.